CytomX Therapeutics, Inc.
CTMX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001501989
No open-market purchases or sales by CytomX Therapeutics, Inc. insiders were filed in the last 90 days; 178 institutions reported holding it in 13F filings for Q2 2026, worth $799.0M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding CytomX Therapeutics, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 67 | 62 | −5 |
| Shares | 34.1M | 32.4M | −1.73M (−5.1%) |
| Value | $58.7M | $41.8M | −$16.9M (−28.8%) |
New holders (3)
Institutions that held CytomX Therapeutics, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Mackenzie Financial Corp | 15,637 | $19.4K | 0.00% |
| Ground Swell Capital, LLC | 10,966 | $14.1K | 0.02% |
| Qube Research & Technologies Ltd | 259 | $334 | 0.00% |
Sold out (8)
Institutions that held CytomX Therapeutics, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Gsa Capital Partners LLP | 344,169 | $592.0K |
| Dimensional Fund Advisors LP | 35,865 | $61.7K |
| Jane Street Group, LLC | 19,364 | $33.3K |
| Advisor Group Holdings, Inc. | 15,350 | $28.6K |
| IPG Investment Advisors LLC | 12,500 | $21.5K |
| Goldman Sachs Group Inc | 10,217 | $17.6K |
| Royal Bank of Canada | 484 | $1.00K |
| Simplex Trading, LLC | 709 | $1.00K |